menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Cervical Cancer Screening: How Co-testing with Pap & HPV Can Make a Difference

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Due to diagnostic declines during the COVID-19 pandemic, optimizing our chances of detecting disease is key. Explore how co-testing may help.

  • Sponsored by

  • Overview

    Pandemic-related declines in screening and diagnosis of cervical cancer have led to an increased burden of disease. In fact, a recent study in the Journal of the American Medical Association showed double-digit declines in cervical cancer diagnoses throughout the first year of the COVID-19 pandemic. These decreases in newly identified cases suggest that many women exist with undiagnosed malignancies. When your patients do come back for their routine well-woman visits, and cervical cancer screening is being done, it’s important to remember that co-testing with Pap and HPV together in women ages 30–65 identifies more cases of cancer and precancer than either Pap or HPV alone. Co-testing can help optimize our ability to detect disease, and here to share evidence on the efficacy of co-testing, the latest guidelines for cervical cancer screening, and more is obstetrician and gynecologist Dr. Monique Rainford.

Schedule28 May 2022
Webpack App